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Abstract 
We  report  a  case  of  an  8-year-old  male
patient  with  Evans  syndrome  and  severe
hypogammaglobulinemia,  subsequently  in
whom the 22q11.2 deletion syndrome (22q11.2
DS) was diagnosed. No other clinical sign of
22q11.2 DS was present with the exception of
slight facial dysmorphism. The case is of par-
ticular interest because it suggests the need to
research  chromosome  22q11.2  deletion  in
patients  who  present  with  autoimmune
cytopenia  and  peculiar  facial  abnormalities,
which could be an atypical presentation of an
incomplete form of 22q11.2 DS.
Introduction
Chromosome  22q11.2  deletion  syndrome
(22q11.2 DS) is considered the most common
human deletion syndrome with an estimated
incidence of 1:4000 live births.
1 More than 90%
of the patients are hemizygous for a 1.5-3 Mb
deletion within the 22q11.2 region.
2 The clin  -
ical expressivity of the syndrome is highly vari-
able  comprising  more  than  100  phenotypes,
the DiGeorge syndrome, velocardiofacial syn-
drome,  and  conotruncal  anomaly  face  syn-
drome being the most frequent. It is character-
ized  mainly  by  facial  anomalies,  congenital
cardiac  defects,  thymic  and  parathyroid
hypoplasia  or  aplasia,  resulting  in  T-cell
immunodeficiency  and  hypocalcemia.  Other
common findings are velopharyngeal insuffi-
ciency, genito-urinary anomalies, learning dif-
ficulties,  and  psychiatric  disorders.  An  early
diagnosis of the syndrome is extremely import  -
ant to assure all the necessary interventions
for the different clinical aspects.
Case Report
A 12-month-old boy presented at our hos  -
pital with mucosal bleeding and diffuse skin
petechiae.  His  previous  clinical  history
revealed that he is the second child of healthy
nonconsanguineous  parents.  Intrauterine
growth retardation was noted during the sec-
ond trimester of gestation. Neonatal seizures
associated with an abnormal EEG occurred at
day 2 of life. At the age of seven months, a V-
grade vesicoureteral reflux was diagnosed and
surgical correction was performed. The baby
was examined by the geneticist who asked for
conventional cytogenetic analysis: the karyo  -
type result was normal (46, XY). At four years
of  age  he  had  three  episodes  of  afebrile
seizures. Magnetic resonance imaging showed
a slight alteration of the focal frontal subcor  -
tical signal, interpreted as a possible outcome
of perinatal hypoxic-ischemic insult.
At the clinical examination the boy was in a
severe  general  condition,  pale  with  scleral
icterus. His liver was palpable 5 cm below the
costal margin, and the spleen was enlarged, 1
cm  below  the  costal  margin.  The  laboratory
assessment showed leukocyte counts of 14600
cells/ʼL,  neutrophils  3400  cells/ʼL,  lympho-
cytes  11060  cells/ʼL,  hemoglobin  4.8  g/dL,
platelets  10000/ʼL,  bilirubin  4.9  mg/dL,  all
unconjugated.  The  direct  Coombs’  test  was
positive.  Serum  immunoglobulin  levels  were
normal  for  his  age  (IgG  518  mg/dL,  IgA  87
mg/dL, IgM 116 mg/dL). The child was treated
with  prednisone  and  intravenous  immuno  -
globulin  (IVIg)  with  complete  resolution  of
symptoms.  In  the  following  years,  recurrent
episodes of bleeding associated with thrombo-
cytopenia and other episodes of acute hemoly-
sis occurred, and a chronic treatment with cor-
ticosteroids was employed; on one occasion a
further IVIg treatment was necessary to recov-
er a good platelet level. Because of the combin  -
ation  of  immune  thrombocytopenia  and
autoimmune  hemolytic  anemia,  Evans  syn-
drome  was  diagnosed.  A  recent  study  has
demonstrated  that  numerous  patients  with
Evans  syndrome  may  have  autoimmune
lympho  prolipherative  syndrome.
3,4 Therefore,
because  of  cytopenia,  persistent  hepato  -
splenomegaly,  and  the  finding  of  cervical
lymph  adenopathy,  FAS-mediated  apoptosis
was analyzed in our patient, despite the nor-
mal  results.  The  number  of  CD3
+CD4
–CD8
–
cells was never tested. Moreover, since the age
of one year he has suffered from recurrent re  -
spiratory infections and frequent episodes of
gastroenteritis.
When he was seven years old, he was admit-
ted to our hospital because of one episode of
fever, coughing, vomiting, and abdominal pain.
A  chest  X-ray  showed  bronchopneumonia.
Laboratory investigations were carried out and
showed low levels of ʳ-globulin on serum pro-
tein electrophoresis (0.35 g/dL; 5.4%, normal
range: 7.7-17%) with normal serum albumin
(4.5 g/dL, 65.5%). Immunoglobulin levels were
tested and found to be impaired: IgG 283 mg/dL
(age-related normal range: 625-1165 mg/dL),
IgA  undetectable,  and  IgM  87  mg/dL.  The
lympho  cyte subsets (Table 1) showed slightly
low CD3
+ and CD4
+ T cells, when compared to
normal  age  values.  Antibody  responses  to
tetanus and to hemophilus B antigens were
poor (tetanus IgG 0.2 IU/mL, hemophilus B IgG
2.5 mg/L). Based on the finding of hypogam-
maglobulinemia  with  normal  B  cell  number,
common variable immunodeficiency was sus-
pected initially and replacement therapy with
intravenous  immunoglobulin  was  started.  A
dose of 400 mg/kg was administrated every 28
days. Because of his clinical history, a second
examination  by  a  clinical  geneticist  was
requested in February 2009: mild but signifi-
cant facial abnormalities were noticed (narrow
palpebral fissures, a slightly bulbous nose with
hypoplastic nares, large and low-set ears), and
a 22q11 DS was clinically suspected and then
confirmed by FISH analysis. Therefore a diag-
nosis of partial DiGeorge syndrome was made.
Consequently,  a  cardiological  evaluation
was performed and no congenital heart defect
was found. The ENT evaluation showed slight
velopharyngeal insufficiency that justified his
nasal speech. Bone mass and metabolism were
normal (ionized and total calcium, phosphate,
parathyroid  hormone,  25-hydroxyvitamin  D,
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1,25-dihydroxyvitamin  D,  serum  osteocalcin
levels,  urinary  deoxipyridinoline  concentra-
tion,  and  dual  energy  X-ray  absorptiometry
were evaluated). Neonatal hypocalcemia was
never detected, and titanic seizures or tremori
were never shown. Besides immunological and
hematological  follow-up,  an  educational
assess  ment was performed and the child was
introduced to a neuropsychological follow-up.
Discussion
The  immunodeficiency  arises  as  a  conse-
quence of thymic hypoplasia in patients with
the deletion syndrome. Patients with a com-
plete  absence  of  the  thymus  (“complete”
DiGeorge  syndrome)  exhibit  severe  T-cell
immu  nodeficiency  with  a  severe  combined
immunodeficiency  phenotype  requiring
immune reconstitution by bone marrow trans-
plantation  or  thymic  transplantation.
5-7
However,  “complete”  DiGeorge  syndrome
accounts for <1% of patients.
8,9 The majority of
patients with 22q11.2 DS and immune defects
exhibit mild to moderate deficits in T-cell num-
bers (so-called “partial” DiGeorge syndrome).
Studies of humoral deficiencies in 22q11.2 DS
patients  have  yielded  conflicting  results.
9-12
Evidence  of  partial  antibody  deficiency  (IgA
deficiency, IgM deficiency, IgG subclass defi-
ciency, specific antibody deficiency, or specific
antibody responses to pneumococcal polysac-
charide antigen) has been reported rarely,
11,13,14
but no mention of a deficiency of almost two
classes of antibodies associated with chromo-
some 22q11.2 DS is found in the literature.
In the 22q11.2 DS, autoimmune disease may
occur in up to 30% of patients and includes
autoimmune  cytopenias,  autoimmune  endo  -
crinopathies,  and  autoimmune  arthritis.
15-18
Previous  studies  reported  cases  of  autoim-
mune hemolytic anemia and immune throm-
bocytopenia,  but  only  a  few  patients  with
Evans syndrome have been described.
15,16,19-21 To
the best of our knowledge, the association of
Evans  syndrome,  hypogammaglobulinemia,
and 22q11.2 DS has not been reported before.
Early diagnosis of 22q11.2 DS is extremely
important for early evaluation of all the clinical
and  functional  aspects  of  the  syndrome
(endocrine, immunological, cardiac, neuropsy-
chiatric, etc.), so as to begin a prompt thera-
peutic program. We concluded that hematolo-
gists  should  consider  the  possibility  of  the
22q11.2 DS in children of all ages who present
with  Evans  syndrome  associated  with  hypo  -
gammaglobulinemia  and  mild  facial  anom-
alies.
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Case Report
Table 1. Lymphocyte subsets – absolute number.
Lymphocytes Patient (cells/µL) Age-related normal value (cells/µL) 
CD19
+ 517 300-700
CD3
+ 1053 1100-2800
CD3
+CD4
+ 574 500-1800
CD3
+CD8
+ 398 400-1200
CD3
–CD16
+CD56
+ 149 100-600
CD4/CD8 1.4 1.4-2.7